OCTA in Epivascular Glia After Dex Implant

Federico II University38 enrolled

Overview

The aim of this prospective study was for the first time, to analyze specific morphologic features in diabetic eyes with macular oedema, such as changes of the foveal avascular zone and the presence of epivascular glia, and see how they would change after dexamethasone intravitreal implant

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diabetic Retinopathy

Interventions

Dexamethasone intravitreal implantDRUG

Dexamethasone intravitreal implant

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * diabetic retinopathy complicated by macular edema Exclusion Criteria: * congenital eye disorders, * previous diagnosis of other ocular diseases * history of vitreous hemorrhage

Locations (1)

University of Naples "Federico II"

Naples, Italy

Outcomes

Primary Outcomes

Changes in epivascular glia after Dexamethasone implant in patients with diabetic retinopathy and inflammatory macular edema

Time frame: up to 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.